China Clinical Trials Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Clinical Trials Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Clinical Trials Overall Market Size
2.1 China Clinical Trials Market Size: 2021 VS 2027
2.2 China Clinical Trials Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Trials Players in China Market
3.2 Top China Clinical Trials Companies Ranked by Revenue
3.3 China Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Clinical Trials Companies in China Market, by Revenue in 2020
3.5 Companies Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Trials Players in China Market
3.6.1 List of Tier 1 Clinical Trials Companies in China
3.6.2 List of Tier 2 and Tier 3 Clinical Trials Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Clinical Trials Market Size Markets, 2021 & 2027
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - China Clinical Trials Revenue & Forecasts
4.2.1 By Type - China Clinical Trials Revenue, 2016-2021
4.2.2 By Type - China Clinical Trials Revenue, 2022-2027
4.2.3 By Type - China Clinical Trials Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Clinical Trials Market Size, 2021 & 2027
5.1.2 Interventional
5.1.3 Observational
5.1.4 Expanded Access
5.2 By Application - China Clinical Trials Revenue & Forecasts
5.2.1 By Application - China Clinical Trials Revenue, 2016-2021
5.2.2 By Application - China Clinical Trials Revenue, 2022-2027
5.2.3 By Application - China Clinical Trials Revenue Market Share, 2016-2027
6 Clinical Trials Companies Profiles
6.1 Quintiles IMS
6.1.1 Quintiles IMS Company Details
6.1.2 Quintiles IMS Business Overview
6.1.3 Quintiles IMS Clinical Trials Introduction
6.1.4 Quintiles IMS Clinical Trials Revenue in China Market (2016-2021)
6.1.5 Quintiles IMS Recent Developments
6.2 Paraxel International Corporation
6.2.1 Paraxel International Corporation Company Details
6.2.2 Paraxel International Corporation Business Overview
6.2.3 Paraxel International Corporation Clinical Trials Introduction
6.2.4 Paraxel International Corporation Clinical Trials Revenue in China Market (2016-2021)
6.2.5 Paraxel International Corporation Recent Developments
6.3 Charles River Laboratories
6.3.1 Charles River Laboratories Company Details
6.3.2 Charles River Laboratories Business Overview
6.3.3 Charles River Laboratories Clinical Trials Introduction
6.3.4 Charles River Laboratories Clinical Trials Revenue in China Market (2016-2021)
6.3.5 Charles River Laboratories Recent Developments
6.4 ICON plc
6.4.1 ICON plc Company Details
6.4.2 ICON plc Business Overview
6.4.3 ICON plc Clinical Trials Introduction
6.4.4 ICON plc Clinical Trials Revenue in China Market (2016-2021)
6.4.5 ICON plc Recent Developments
6.5 SGS SA
6.5.1 SGS SA Company Details
6.5.2 SGS SA Business Overview
6.5.3 SGS SA Clinical Trials Introduction
6.5.4 SGS SA Clinical Trials Revenue in China Market (2016-2021)
6.5.5 SGS SA Recent Developments
6.6 Pharmaceutical Product Development, LLC
6.6.1 Pharmaceutical Product Development, LLC Company Details
6.6.2 Pharmaceutical Product Development, LLC Business Overview
6.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
6.6.4 Pharmaceutical Product Development, LLC Clinical Trials Revenue in China Market (2016-2021)
6.6.5 Pharmaceutical Product Development, LLC Recent Developments
6.7 Wuxi AppTec Inc.
6.7.1 Wuxi AppTec Inc. Company Details
6.7.2 Wuxi AppTec Inc. Business Overview
6.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
6.7.4 Wuxi AppTec Inc. Clinical Trials Revenue in China Market (2016-2021)
6.7.5 Wuxi AppTec Inc. Recent Developments
6.8 PRA Health Sciences
6.8.1 PRA Health Sciences Company Details
6.8.2 PRA Health Sciences Business Overview
6.8.3 PRA Health Sciences Clinical Trials Introduction
6.8.4 PRA Health Sciences Clinical Trials Revenue in China Market (2016-2021)
6.8.5 PRA Health Sciences Recent Developments
6.9 Chiltern International Ltd.
6.9.1 Chiltern International Ltd. Company Details
6.9.2 Chiltern International Ltd. Business Overview
6.9.3 Chiltern International Ltd. Clinical Trials Introduction
6.9.4 Chiltern International Ltd. Clinical Trials Revenue in China Market (2016-2021)
6.9.5 Chiltern International Ltd. Recent Developments
6.10 INC Research
6.10.1 INC Research Company Details
6.10.2 INC Research Business Overview
6.10.3 INC Research Clinical Trials Introduction
6.10.4 INC Research Clinical Trials Revenue in China Market (2016-2021)
6.10.5 INC Research Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Clinical Trials Market Opportunities & Trends in China Market
Table 2. Clinical Trials Market Drivers in China Market
Table 3. Clinical Trials Market Restraints in China Market
Table 4. Key Players of Clinical Trials in China Market
Table 5. Top Clinical Trials Players in China Market, Ranking by Revenue (2019)
Table 6. China Clinical Trials Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Clinical Trials Revenue Share by Companies, 2016-2021
Table 8. Companies Clinical Trials Product Type
Table 9. List of Tier 1 Clinical Trials Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Clinical Trials Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Clinical Trials Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Clinical Trials Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Clinical Trials Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Clinical Trials Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Clinical Trials Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Clinical Trials Revenue (US$, Mn), 2022-2027
Table 17. Quintiles IMS Company Details
Table 18. Quintiles IMS Business Overview
Table 19. Quintiles IMS Clinical Trials Product
Table 20. Quintiles IMS Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Quintiles IMS Recent Developments
Table 22. Paraxel International Corporation Company Details
Table 23. Paraxel International Corporation Business Overview
Table 24. Paraxel International Corporation Clinical Trials Product
Table 25. Paraxel International Corporation Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Paraxel International Corporation Recent Developments
Table 27. Charles River Laboratories Company Details
Table 28. Charles River Laboratories Business Overview
Table 29. Charles River Laboratories Clinical Trials Product
Table 30. Charles River Laboratories Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Charles River Laboratories Recent Developments
Table 32. ICON plc Company Details
Table 33. ICON plc Business Overview
Table 34. ICON plc Clinical Trials Product
Table 35. ICON plc Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 36. ICON plc Recent Developments
Table 37. SGS SA Company Details
Table 38. SGS SA Business Overview
Table 39. SGS SA Clinical Trials Product
Table 40. SGS SA Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 41. SGS SA Recent Developments
Table 42. Pharmaceutical Product Development, LLC Company Details
Table 43. Pharmaceutical Product Development, LLC Business Overview
Table 44. Pharmaceutical Product Development, LLC Clinical Trials Product
Table 45. Pharmaceutical Product Development, LLC Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Pharmaceutical Product Development, LLC Recent Developments
Table 47. Wuxi AppTec Inc. Company Details
Table 48. Wuxi AppTec Inc. Business Overview
Table 49. Wuxi AppTec Inc. Clinical Trials Product
Table 50. Wuxi AppTec Inc. Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Wuxi AppTec Inc. Recent Developments
Table 52. PRA Health Sciences Company Details
Table 53. PRA Health Sciences Business Overview
Table 54. PRA Health Sciences Clinical Trials Product
Table 55. PRA Health Sciences Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 56. PRA Health Sciences Recent Developments
Table 57. Chiltern International Ltd. Company Details
Table 58. Chiltern International Ltd. Business Overview
Table 59. Chiltern International Ltd. Clinical Trials Product
Table 60. Chiltern International Ltd. Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Chiltern International Ltd. Recent Developments
Table 62. INC Research Company Details
Table 63. INC Research Business Overview
Table 64. INC Research Clinical Trials Product
Table 65. INC Research Clinical Trials Revenue in China Market (2016-2021) & (US$ Million)
Table 66. INC Research Recent Developments
List of FiguresFigure 1. Clinical Trials Segment by Type
Figure 2. Clinical Trials Segment by Application
Figure 3. China Clinical Trials Market Overview: 2020
Figure 4. China Clinical Trials Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Clinical Trials Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Clinical Trials Revenue in 2020
Figure 7. By Type - China Clinical Trials Revenue Market Share, 2016-2027
Figure 8. By Application - China Clinical Trials Revenue Market Share, 2016-2027
Figure 9. Quintiles IMS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Paraxel International Corporation Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Charles River Laboratories Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. ICON plc Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. SGS SA Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pharmaceutical Product Development, LLC Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Wuxi AppTec Inc. Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. PRA Health Sciences Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Chiltern International Ltd. Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. INC Research Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2016-2021)